Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Nature Immunology
|
March 28, 2003
Proteases, proteases and proteases for presentation
Carla Herberts, Eric Reits, Jacques Neefjes
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 19, 2013
The evolution of nonclinical regulatory science: advanced therapy medicinal products as a paradigm
Henrik Tang Vestergaard, Lucia D'Apote, Christian K Schneider, et al.
Expert Review of Vaccines
|
November 26, 2010
New adjuvanted vaccines in pregnancy: what is known about their safety?
Carla Herberts, Barbro Melgert, Jan Willem van der Laan, et al.
Nature
|
March 4, 2005
Cross-presentation by intercellular peptide transfer through gap junctions
Joost Neijssen, Carla Herberts, Jan Wouter Drijfhout, et al.
Immunity
|
April 16, 2004
A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation
Eric Reits, Joost Neijssen, Carla Herberts, et al.
British Journal of Clinical Pharmacology
|
September 16, 2020
Animal-free applications in the development of cell-based therapies
Peter van Meer, Peter Theunissen, Tineke van den Hoorn, et al.
Drug Discovery Today
|
April 28, 2016
Development of cell therapy medicinal products by academic institutes
Sofieke de Wilde, Henk-Jan Guchelaar, Carla Herberts, et al.
Clinical Pharmacology and Therapeutics
|
May 2, 2023
European Conditional Marketing Authorization in a Rapidly Evolving Treatment Landscape: A Comprehensive Study of Anticancer Medicinal Products in 2006-2020
Lourens T Bloem, Jasmin Schelhaas, Lucía López-Anglada, et al.
Advances in Experimental Medicine and Biology
|
August 1, 2023
Marketing Regulatory Oversight of Advanced Therapy Medicinal Products in Europe
Martina Schuessler-Lenz, Carla Herberts, Ilona Reischl, et al.
Expert Review of Vaccines
|
July 31, 2008
Animal models in influenza vaccine testing
Jan Willem van der Laan, Carla Herberts, Robert Lambkin-Williams, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Nature Immunology
|
March 28, 2003
Proteases, proteases and proteases for presentation
Carla Herberts, Eric Reits, Jacques Neefjes
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 19, 2013
The evolution of nonclinical regulatory science: advanced therapy medicinal products as a paradigm
Henrik Tang Vestergaard, Lucia D'Apote, Christian K Schneider, et al.
Expert Review of Vaccines
|
November 26, 2010
New adjuvanted vaccines in pregnancy: what is known about their safety?
Carla Herberts, Barbro Melgert, Jan Willem van der Laan, et al.
Nature
|
March 4, 2005
Cross-presentation by intercellular peptide transfer through gap junctions
Joost Neijssen, Carla Herberts, Jan Wouter Drijfhout, et al.
Immunity
|
April 16, 2004
A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation
Eric Reits, Joost Neijssen, Carla Herberts, et al.
British Journal of Clinical Pharmacology
|
September 16, 2020
Animal-free applications in the development of cell-based therapies
Peter van Meer, Peter Theunissen, Tineke van den Hoorn, et al.
Drug Discovery Today
|
April 28, 2016
Development of cell therapy medicinal products by academic institutes
Sofieke de Wilde, Henk-Jan Guchelaar, Carla Herberts, et al.
Clinical Pharmacology and Therapeutics
|
May 2, 2023
European Conditional Marketing Authorization in a Rapidly Evolving Treatment Landscape: A Comprehensive Study of Anticancer Medicinal Products in 2006-2020
Lourens T Bloem, Jasmin Schelhaas, Lucía López-Anglada, et al.
Advances in Experimental Medicine and Biology
|
August 1, 2023
Marketing Regulatory Oversight of Advanced Therapy Medicinal Products in Europe
Martina Schuessler-Lenz, Carla Herberts, Ilona Reischl, et al.
Expert Review of Vaccines
|
July 31, 2008
Animal models in influenza vaccine testing
Jan Willem van der Laan, Carla Herberts, Robert Lambkin-Williams, et al.
Page
of 2